Cite
HARVARD Citation
Fennell, D. et al. (2022). Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial. EClinicalMedicine. p. . [Online].